HSBC plans phoenix quarterly review notes linked to Gilead Sciences

By Angela McDaniels

Tacoma, Wash., Sept. 13 – HSBC USA Inc. plans to price phoenix quarterly review notes due Oct. 4, 2017 linked to the common stock of Gilead Sciences, Inc., according to an FWP filing with the Securities and Exchange Commission.

Each quarter, the notes will pay a contingent coupon at the rate of 14.6% per year if Gilead Sciences stock closes at or above the barrier price, 80% of the initial share price, on the observation date for that quarter.

The notes will be called at par plus the contingent coupon if Gilead Sciences shares close at or above the initial share price on any quarterly observation date.

If the notes are not called and Gilead Sciences shares finish at or above the barrier price, the payout at maturity will be par plus the contingent coupon. Otherwise, investors will be exposed to the decline in the share price.

HSBC Securities (USA) Inc. is the underwriter, and J.P. Morgan Securities LLC and JPMorgan Chase Bank NA are placement agents.

The notes will price Sept. 16.

The Cusip number is 40433UVL7.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.